Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.180
-0.050 (-4.07%)
At close: Mar 5, 2026, 4:00 PM EST
1.180
0.00 (0.00%)
After-hours: Mar 5, 2026, 6:30 PM EST

Actinium Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Actinium Pharmaceuticals stock has a target of 4.00, which predicts an increase of 238.98% from the current stock price of 1.18.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $4.00 $4.00 $4.00 $4.00
Change +238.98% +238.98% +238.98% +238.98%
* Price targets were last updated on Jun 24, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Actinium Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Sep '25Oct '25Nov '25Dec '25Jan '26Feb '26
Strong Buy 222221
Buy 111110
Hold 000000
Sell 000000
Strong Sell 000000
Total 333331

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +238.98% Jun 24, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +238.98% May 12, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +238.98% Apr 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +238.98% Apr 1, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +238.98% Mar 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
91.80K
Revenue Next Year
n/a
from 91.80K
EPS This Year
-1.10
from -1.27
EPS Next Year
-0.76
from -1.10
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-1.14M1.03M81.00K-91.80K-
Revenue Growth
---9.97%-92.14%---
EPS
-1.83-1.20-1.37-1.83-1.27-1.10-0.76
EPS Growth
-------
Forward PE
-------
No. Analysts -----66
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High 94,500 n/a
Avg 91,800 n/a
Low 88,200 n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -1.12 -0.64
Avg -1.10 -0.76
Low -1.07 -0.82

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.